Neogen (NEOG) Liabilities and Shareholders Equity (2010 - 2026)
Neogen (NEOG) posted quarterly Liabilities and Shareholders Equity of $3.3 billion for Q2 2026, down 2.84% year-over-year from $3.4 billion in Q2 2025, and little changed quarter-over-quarter from $3.4 billion in Q1 2026.
Neogen (NEOG) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
Neogen's Liabilities and Shareholders Equity history runs 17 years deep, the most recent figure standing at $3.3 billion for Q2 2026.
- In Q2 2026, Liabilities and Shareholders Equity fell 2.84% year-over-year to $3.3 billion; the TTM figure through May 2026 stood at $13.4 billion (down 18.94% YoY), while the FY2026 annual figure was $3.3 billion, down 2.84% from the prior year.
- Liabilities and Shareholders Equity for Q2 2026 stood at $3.3 billion, roughly flat from $3.4 billion in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $4.6 billion in Q4 2023, with the low at $977.4 million in Q3 2022.
- The 5-year median for Liabilities and Shareholders Equity is $4.3 billion (2024), against an average of $3.6 billion.
- The sharpest annual moves came in 2022 and 2026: Liabilities and Shareholders Equity soared 371.44% in 2022, then decreased 26.7% in 2026.
- Neogen's Liabilities and Shareholders Equity stood at $4.6 billion in 2022, then advanced by 0.86% to $4.6 billion in 2023, then retreated by 11.91% to $4.1 billion in 2024, then retreated by 17.12% to $3.4 billion in 2025, then dropped by 0.42% to $3.3 billion in 2026.
- Business Quant data shows NEOG's Liabilities and Shareholders Equity at $3.3 billion in Q2 2026, $3.4 billion in Q1 2026, and $3.4 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 47.93 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 13.87 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 6.46 Bn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 37.25 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 31.04 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Neogen | 2.61 Bn | 2.42 Bn | 107.80 Mn | 3.35 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 3.35 Bn |
| Feb 28, 2026 | 3.36 Bn |
| Nov 30, 2025 | 3.36 Bn |
| Aug 31, 2025 | 3.38 Bn |
| May 31, 2025 | 3.44 Bn |
| Feb 28, 2025 | 344.20 Mn |
| Nov 30, 2024 | 140.23 Mn |
| Aug 31, 2024 | 4.06 Bn |
| May 31, 2024 | 4.55 Bn |
| Feb 29, 2024 | 4.58 Bn |
| Nov 30, 2023 | 4.60 Bn |
| Aug 31, 2023 | 4.56 Bn |
| May 31, 2023 | 4.55 Bn |
| Feb 28, 2023 | 4.51 Bn |
| Nov 30, 2022 | 4.56 Bn |
| Aug 31, 2022 | 977.41 Mn |
| May 31, 2022 | 992.93 Mn |
| Feb 28, 2022 | 981.21 Mn |
| Nov 30, 2021 | 967.93 Mn |
| Aug 31, 2021 | 932.11 Mn |